Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 100801-100850 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04557098
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
PHASE2Active, not recruiting
194 participants
Started: Sep 17, 2020 · Completed: May 28, 2027
1 condition1 sponsor51 locations
NCT04625907
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
PHASE1/PHASE2Recruiting
1,672 participants
Started: Sep 17, 2020 · Completed: Jun 30, 2030
1 condition1 sponsor128 locations
NCT04877912
Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening
N/ARecruiting
200 participants
Started: Sep 17, 2020 · Completed: Sep 14, 2024
1 condition1 sponsor1 location
NCT04469530
Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors
PHASE2Recruiting
50 participants
Started: Sep 16, 2020 · Completed: Nov 30, 2026
1 condition2 sponsors5 locations
NCT04578418
Effect of Collagen Supplementation on Tendinopathy
NAActive, not recruiting
64 participants
Started: Sep 16, 2020 · Completed: May 1, 2025
1 condition3 sponsors1 location
NCT04544046
Supportive Oncology Care At Home RCT
NAActive, not recruiting
300 participants
Started: Sep 16, 2020 · Completed: Dec 31, 2025
5 conditions2 sponsors1 location
NCT04568044
Evaluation of Humoral Immunity Following COVID-19 in Pregnancy
N/AActive, not recruiting
128 participants
Started: Sep 16, 2020 · Completed: Jan 1, 2025
3 conditions1 sponsor2 locations
NCT04064827
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)
PHASE3Active, not recruiting
16 participants
Started: Sep 16, 2020 · Completed: Mar 31, 2027
2 conditions1 sponsor15 locations
NCT04522336
Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer
PHASE1Active, not recruiting
16 participants
Started: Sep 16, 2020 · Completed: Jul 18, 2027
19 conditions2 sponsors1 location
NCT04213547
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
NARecruiting
90 participants
Started: Sep 16, 2020 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT04552288
Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies
PHASE2Active, not recruiting
51 participants
Started: Sep 16, 2020 · Completed: Mar 16, 2026
4 conditions1 sponsor5 locations
NCT04610112
Safety and Performance of HiResTM Ultra/Ultra 3D Cl Mid-Scala Electrodes in Adults With Severe-to-profound Hearing Loss
N/ARecruiting
30 participants
Started: Sep 16, 2020 · Completed: May 31, 2025
1 condition1 sponsor3 locations
NCT04551742
Social & Contextual Impact on Children Undergoing Liver Transplantation
N/AActive, not recruiting
500 participants
Started: Sep 16, 2020 · Completed: Apr 30, 2026
2 conditions1 sponsor8 locations
NCT04567056
Specific Methylation Profiles in HNSCC
N/ARecruiting
300 participants
Started: Sep 16, 2020 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT06880289
Chemo-Radiotherapy Boost Treatment Guided by Perfusion MRI on Hypoxic Zones in Head and Neck Cancer
PHASE2Active, not recruiting
91 participants
Started: Sep 16, 2020 · Completed: Jul 31, 2027
1 condition1 sponsor2 locations
NCT04440280
Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy
PHASE2Recruiting
45 participants
Started: Sep 16, 2020 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT04518748
Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.
PHASE1Recruiting
70 participants
Started: Sep 16, 2020 · Completed: Nov 30, 2028
1 condition3 sponsors1 location
NCT04551807
Natural Versus Programmed Frozen Embryo Transfer (NatPro)
PHASE3Active, not recruiting
788 participants
Started: Sep 16, 2020 · Completed: Apr 1, 2026
2 conditions1 sponsor15 locations
NCT04550455
A Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine Tablets
PHASE4Recruiting
30 participants
Started: Sep 16, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04288726
Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas
PHASE1Recruiting
18 participants
Started: Sep 16, 2020 · Completed: Jun 1, 2037
2 conditions2 sponsors2 locations
NCT04791098
Impact of Infectious Diseases Consultation on Vaccination Coverage Among People Waiting for a Kidney Transplant at the Clermont-Ferrand Hospital
NARecruiting
150 participants
Started: Sep 16, 2020 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT04379414
YES Study - Newly Diagnosed/Metastatic Intervention
NARecruiting
400 participants
Started: Sep 16, 2020 · Completed: Mar 1, 2028
2 conditions2 sponsors1 location
NCT04553133
PF-07104091 as a Single Agent and in Combination Therapy
PHASE2Active, not recruiting
154 participants
Started: Sep 16, 2020 · Completed: Mar 30, 2026
3 conditions1 sponsor46 locations
NCT04547725
Complete Cytoreduction Followed by IP and Systemic Chemotherapies for Gastric Cancer With Peritoneal Carcinomatosis
NARecruiting
48 participants
Started: Sep 16, 2020 · Completed: Sep 16, 2028
2 conditions1 sponsor1 location
NCT05602935
Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study
PHASE2Active, not recruiting
29 participants
Started: Sep 16, 2020 · Completed: Dec 30, 2026
6 conditions1 sponsor1 location
NCT04074863
Norwegian Distal Ulna Resection - Replacement Study
NARecruiting
40 participants
Started: Sep 16, 2020 · Completed: Dec 31, 2029
1 condition1 sponsor6 locations
NCT04209127
Comparing Efficacy of Microwave Vs Embolization Treatment for Adenomyosis
NARecruiting
70 participants
Started: Sep 16, 2020 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT04140526
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC
PHASE1/PHASE2Active, not recruiting
733 participants
Started: Sep 16, 2020 · Completed: Dec 31, 2027
19 conditions2 sponsors37 locations
NCT04384484
Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
PHASE3Active, not recruiting
440 participants
Started: Sep 16, 2020 · Completed: Jun 30, 2028
2 conditions1 sponsor144 locations
NCT04503278
A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors
PHASE1Recruiting
214 participants
Started: Sep 16, 2020 · Completed: Jan 31, 2041
1 condition1 sponsor12 locations
NCT04530110
A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents
PHASE3Active, not recruiting
506 participants
Started: Sep 16, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor70 locations
NCT04681040
Risk Stratification of COVID-19 Using Urine Biomarkers
N/AActive, not recruiting
964 participants
Started: Sep 15, 2020 · Completed: Mar 25, 2024
4 conditions1 sponsor7 locations
NCT03636230
Remote Patient Management of CIEDs - Brady Devices
NARecruiting
848 participants
Started: Sep 15, 2020 · Completed: Jun 30, 2025
1 condition4 sponsors11 locations
NCT04507555
Pharmacist Guided Pre-emptive Pharmacogenetic Testing in Antidepressant Therapy
NARecruiting
190 participants
Started: Sep 15, 2020 · Completed: Dec 31, 2025
1 condition5 sponsors4 locations
NCT04716140
Prospective Study: The Effect on Clinical Outcome After Treatment of MTP Cartilage Lesions in Hallux Valgus Surgery
NARecruiting
99 participants
Started: Sep 15, 2020 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04404465
Health eHeart BEAT-AFib - Health eHeart Biomarkers of Early Atrial Transformation in Atrial Fibrillation
N/AEnrolling by invitation
3,000 participants
Started: Sep 15, 2020 · Completed: Sep 15, 2040
1 condition1 sponsor1 location
NCT04644952
The Rise in Robotic Atypical Segmentectomies
N/ARecruiting
600 participants
Started: Sep 15, 2020 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT04513626
HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label
PHASE2Recruiting
150 participants
Started: Sep 15, 2020 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT04430738
Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers
PHASE2Active, not recruiting
40 participants
Started: Sep 15, 2020 · Completed: Sep 30, 2025
6 conditions1 sponsor28 locations
NCT06031038
Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU
NAActive, not recruiting
290 participants
Started: Sep 15, 2020 · Completed: Jun 30, 2025
4 conditions1 sponsor30 locations
NCT06360562
Reconnecting to Ourselves and Others in Virtual Meetings (ROOM)
NAActive, not recruiting
174 participants
Started: Sep 15, 2020 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04316117
Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study
PHASE2Active, not recruiting
138 participants
Started: Sep 15, 2020 · Completed: Aug 31, 2027
4 conditions2 sponsors104 locations
NCT04583514
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
NARecruiting
58 participants
Started: Sep 15, 2020 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT06345352
Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (Fondazione IRCCS Ca' Granda Ospedale Maggione Policlinico)
N/AActive, not recruiting
1,200 participants
Started: Sep 15, 2020 · Completed: Dec 31, 2027
4 conditions1 sponsor1 location
NCT04904068
Functional Neuroimaging in Parkinson's Disease
N/AActive, not recruiting
40 participants
Started: Sep 15, 2020 · Completed: Nov 2, 2025
2 conditions1 sponsor1 location
NCT04541654
Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress
N/ARecruiting
1,500 participants
Started: Sep 15, 2020 · Completed: Dec 31, 2025
5 conditions4 sponsors3 locations
NCT04108741
Augmented Reality Treadmill Training in Patients With Parkinson's Disease
NARecruiting
50 participants
Started: Sep 15, 2020 · Completed: Nov 30, 2025
2 conditions1 sponsor1 location
NCT04717024
The Nanowear Wearable Covid-19 Observational and Analysis Trend
N/ARecruiting
100 participants
Started: Sep 15, 2020 · Completed: Dec 31, 2023
1 condition1 sponsor2 locations
NCT04526691
Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)
PHASE1Active, not recruiting
145 participants
Started: Sep 15, 2020 · Completed: Apr 15, 2026
1 condition2 sponsors24 locations
NCT04282356
Intensive Intraperitoneal Therapy in Advanced Ovarian Cancer
PHASE2Recruiting
55 participants
Started: Sep 15, 2020 · Completed: Dec 31, 2030
2 conditions2 sponsors1 location